Skip to main
University-wide Navigation

Sanders-Brown researcher receives $1.7 million to study adverse effects of Alzheimer’s drugs

Donna Wilcock, Ph.D., was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs shown to slow the progression of cognitive decline.

UK researcher explores multisensory approach as potential treatment for Alzheimer’s patients

The focus of the work done by Elizabeth Rhodus, Ph.D., is to enhance sensory input in order to improve behavioral symptoms in people with Alzheimer's disease and related dementias.

Journal announces UK's Donna Wilcock as new editor-in-chief

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, Ph.D., as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

Sanders-Brown researchers receive $20.5 million from National Institute on Aging

The award exemplifies team science, helping to support 35 researchers across six different labs on four main projects on astrocytes.

Sanders-Brown director receives funding to advance work

Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer’s disease.

Fardo Honored as 2022-23 University Research Professor

David Fardo, Stephen W. Wyatt Endowed Professor in the College of Public Health, is one of 14 University Research Professors for 2022-23. He conducts research on dementia-related neuropathologies.

UK Develops Support for People With Mild Cognitive Impairment, Caregivers

College of Social Work's Allison Gibson, Ph.D., is working to address a lack of information and services for people with a diagnosis of mild cognitive impairment, which often leads to dementia and Alzheimer's disease.

UK Researcher Highlights Need to Improve Alzheimer's and Dementia Cognitive Screenings and Assessments

A researcher at the UK’s Sanders-Brown Center on Aging is one of several experts in the field who recently discussed the use of two popular screening tests for dementia and Alzheimer’s disease.

UK Study Identifies Therapeutic Targets for Alzheimer’s Disease

A new UK College of Medicine study has identified potential targets to develop a therapy that could prevent Alzheimer’s disease. 

Study Indicates High Prevalence of Recently Defined Non-Alzheimer’s Dementia

Research published from the Sanders-Brown Center on Aging is providing the most definitive assessment yet of the prevalence of a form of dementia classified in 2019 and now known as LATE.